Morphic Medical

Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes

A total of 1,064 studies were identified, 147 of which were duplicates. After abstract review, 741 studies were excluded, leaving 176 articles for full manuscript review. Full article review resulted in 17 studies that satisfied all criteria and therefore were...


Efforts are being made to kick-start further development of a duodenal-jejunal bypass liner, the EndoBarrier (GI Dynamics), this time specifically for use in obese patients with type 2 diabetes, after some issues with the device in earlier trials.

A Randomised Controlled Trial of a Duodenal-Jejunal Bypass Sleeve Device (EndoBarrier) Compared with Standard Medical Therapy for the Management of Obese Subjects with Type 2 Diabetes Mellitus

Endoscopically placed duodenal-jejunal bypass sleeve devices, such as the EndoBarrier (GI Dynamics, Lexington, Massachusetts, USA), have been designed to create an impermeable barrier between chyme exiting the stomach and the mucosa of the duodenum and proximal...